Evogene Ltd Share Price Today: Live Updates & Key Insights

Evogene Ltd share price today is $0.8889, up -0.09%. The stock opened at $0.8899 against the previous close of $0.8468, with an intraday high of $0.8899 and low of $0.8288.

Evogene Ltd Share Price Chart

Evogene Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Evogene Ltd Share Price Performance

$0.8889 -0.0009(-0.09%) EVGN at 23 Mar 2026 12:56 PM Biotechnology
Lowest Today 0.8288
Highest Today 0.8899
Today’s Open 0.8899
Prev. Close 0.8468
52 Week High 2.42
52 Week Low 0.73
Day’s Range: Low 0.8288 High 0.8899
52-Week Range: Low 0.73 High 2.42
1 day return -
1 Week return +5.47
1 month return -0.88
3 month return -18.44
6 month return -28.81
1 year return -31.7
3 year return +29.23
5 year return -84.5
10 year return -

Evogene Ltd Institutional Holdings

Citadel Advisors Llc 1.02

Jane Street Group LLC 0.44

Morgan Stanley - Brokerage Accounts 0.35

BNP Paribas Arbitrage, SA 0.12

P & S Renditefonds T 0.11

Daytona Street Capital LLC 0.11

Fidelity Nasdaq Composite Index 0.05

UBS Group AG 0.01

Altshuler Shaham Ltd 0.01

Steward Partners Investment Advisory, LLC 0.01

Federation des caisses Desjardins du Quebec 0.01

Bank of America Corp 0.00

Advisor Group Holdings, Inc. 0.00

Tradewinds Capital Management, LLC 0.00

SBI Securities Co Ltd 0.00

Royal Bank of Canada 0.00

TWO SIGMA SECURITIES, LLC 0.00

U.S. Bancorp 0.00

Virtu Financial LLC 0.00

Evogene Ltd Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Evogene Ltd Fundamentals

Market Cap 7.78 M

PB Ratio 6.176

PE Ratio 0.0

Enterprise Value -3.29 M

Total Assets 20.05 M

Volume 95525

Evogene Ltd Company Financials

Annual Revenue FY23:5722000 5.7M, FY22:1675000 1.7M, FY21:930000 0.9M, FY20:1040000 1.0M, FY19:753000 0.8M

Annual Profit FY23:4064000 4.1M, FY22:766000 0.8M, FY21:163000 0.2M, FY20:466000 0.5M, FY19:419000 0.4M

Annual Net worth FY23:-20276000 -20.3M, FY22:-29844000 -29.8M, FY21:-30445000 -30.4M, FY20:-26206000 -26.2M, FY19:-19115000 -19.1M

Quarterly Revenue Q3/2025:312000 0.3M, Q2/2025:884000 0.9M, Q1/2025:2444000 2.4M, Q3/2024:1796000 1.8M, Q2/2024:914000 0.9M

Quarterly Profit Q3/2025:-126000 -0.1M, Q2/2025:458000 0.5M, Q1/2025:251000 0.3M, Q3/2024:715000 0.7M, Q2/2024:-236000 -0.2M

Quarterly Net worth Q3/2025:3874000 3.9M, Q2/2025:-4462000 -4.5M, Q1/2025:-2587000 -2.6M, Q3/2024:-7630000 -7.6M, Q2/2024:-5419000 -5.4M

About Evogene Ltd & investment objective

Company Information Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop Novel Therapies forfor hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.

Organisation Biotechnology

Employees 117

Industry Biotechnology

CEO Mr. Ofer Haviv CPA

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Evogene Ltd FAQs

What is the share price of Evogene Ltd today?

The current share price of Evogene Ltd is $0.8889.

Can I buy Evogene Ltd shares in India?

Yes, Indian investors can buy Evogene Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Evogene Ltd shares in India?

You can easily invest in Evogene Ltd shares from India by:

Can I buy fractional shares of Evogene Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Evogene Ltd?

Evogene Ltd has a market cap of $7.78 M.

In which sector does Evogene Ltd belong?

Evogene Ltd operates in the Biotechnology sector.

What documents are required to invest in Evogene Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Evogene Ltd?

The PE ratio of Evogene Ltd is N/A and the PB ratio is 6.18.